Stroke [stroke].
Case narrative: this case is cross referenced with case: (b)(4) (cluster case).
Initial information received on 12-mar-2019 from united states regarding an unsolicited valid serious case received from a non-healthcare professional this case involves a (b)(6) male patient who experienced stroke, 2 days after, he used the medical device of hylan g-f 20, sodium hyaluronate (synvisc one).
The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.
On an unknown date, the patient took hylan g-f 20, sodium hyaluronate injection at unknown dosage unknown frequency via intra-articular route (lot number- unknown) for unknown indication.
On the unknown date, patient experienced a stroke after 2 days of injection.
Final diagnosis was stroke.
Corrective treatment: not reported for stroke.
Outcome: unknown for stroke.
Seriousness criteria: medically significant for stroke.
A product technical complaint was initiated, and results were pending for same.
|